Rapid Therapeutic Science Laboratories, Inc. (RTSL)

USD 0.0

(0.0%)

Annual Income Statements

(In USD)
Breakdown 2022 2021 2020 2018 2017 2016
Revenue - 534.00 9139.00 - - -
Cost of Revenue - 200.00 7155.00 - - -
Gross Profit - 334.00 1984.00 - - -
Operating Expenses 1.26 Million 2.17 Million 169.69 Thousand 152.07 Thousand 21.61 Thousand 12.02 Thousand
Selling, General and Administrative Expenses 1.23 Million 2.11 Million 169.69 Thousand 135.68 Thousand 21.61 Thousand 12.02 Thousand
Research and Development Expenses - - - - - -
Other Expenses 23.97 Thousand 55.85 Thousand - 16.39 Thousand - -
Cost and Expenses 1.26 Million 2.17 Million 169.69 Thousand 152.07 Thousand 21.61 Thousand 12.02 Thousand
Operating Income -1.26 Million -2.17 Million -169.69 Thousand -2.52 Million -21.61 Thousand -12.02 Thousand
Interest Expense 1.89 Million 1.32 Million 180.53 Thousand 28.6 Thousand - -
Income Tax Expense -100.92 Thousand 1.32 Million -1380.00 28.6 Thousand - -
Earnings before Tax -1.79 Million -2.86 Million -348.84 Thousand -2.55 Million -21.61 Thousand -12.02 Thousand
Net Income -1.69 Million -4.19 Million -348.84 Thousand -2.55 Million -21.61 Thousand -12.02 Thousand
Earnings Per Share Basic -0.22 -0.55 -7.24 -25.88 -0.20 -0.11
Earnings Per Share Diluted -0.22 -0.55 -7.24 -25.88 -0.20 -0.11
Weighted Average Shares Outstanding 7.74 Million 7.62 Million 48.16 Thousand 98.64 Thousand 108.4 Thousand 108.4 Thousand
Weighted Average Shares Outstanding (Diluted) 7.74 Million 7.62 Million 48.16 Thousand 98.64 Thousand 108.4 Thousand 108.4 Thousand
Gross Margin - 0.63 0.22 - - -
EBIT Margin - -3959.62 -18.57 - - -
Profit Margin - -7860.16 -38.17 - - -
EBITDA -1.23 Million -2.11 Million -169.69 Thousand -135.68 Thousand -21.61 Thousand -12.02 Thousand
Earnings Before Tax Margin - -4064.22 -18.57 - - -

Income Statement Charts